Is your field team fully optimised?

  • Pharma success hinges on field engagement. Despite it representing a large investment, significant opportunities remain to optimise both the quality and impact of critical interactions.
  • Established in 2016, we are global experts in pharma in-field enablement delivering growth & performance of individuals, teams and organisations.
  • We innovate by harnessing the power of market-leading AI Conversation Intelligence to drive unrivalled field engagement insight - fusing this technology with human expertise to maximise adoption and value gain.
  • We design and deliver tailored, blended learning journeys as part of a continual learning cycle, using expert capability building and coaching support to drive the performance of your people.

The opportunity that exists to optimise field force teams

Money
Money
Money
Money
Money
Money
Money
Money
Money
Money
20-30%
Proportion of revenues invested by Pharma in field teams and engagements
Speech Bubble
Speech Bubble
Speech Bubble
Speech Bubble
Speech Bubble
Speech Bubble
Speech Bubble
Speech Bubble
Speech Bubble
Speech Bubble
30%
Proportion of engagements that HCPs state are useful

At NeoOptima, we accelerate field force effectiveness via a continual learning cycle, whilst leveraging the power of AI insights

Discovery & Insight

Deep needs analysis and provision of rich insights on how your field teams are engaging - harnessing the power of AI Conversational Analytics.

Coaching & Training Interventions

We design and deliver tailored, blended learning journeys all laser-focused on specific, objective insights. No broad strokes.

3-part cycle
to optimise field engagement & effectiveness

Impact & ROI

We measure intervention impact and return on investment, creating a continuous cycle of improvement.

The High Stakes of Learning and Performance

  • “The single biggest driver of business impact is the strength of an organization's learning culture.”*— Without a strong learning culture, business performance suffers
  • Organizations that fail to embed learning into their culture risk stagnation and underperformance**.
  • Talent retention suffers: Companies that don't prioritize development struggle to retain top talent, especially in competitive and fast-changing industries.**
*Josh Bersin - globally recognized thought leader in corporate learning
**Kevin McAlpin & Dani Saadu, The CAPEX Formula™ for Learning and Performance
The High Stakes of Learning and Performance

Why are we the preferred provider in the market?

  • Depth of experience & heritage
    Depth of experience & heritage
    A decade of capability development heritage across 55+ markets & 30+ healthcare client organisations
  • Unique combination of expertise
    Unique combination of expertise
    Deep development and coaching expertise, senior functional subject-matter specialists & ex-pharma c-suite experience
  • Global coaching network
    Global coaching network
    Large pool of highly-experienced coaching, design and facilitation associates with local language capability
  • NeoOptima-KAI partnership
    NeoOptima-KAI partnership
    We combine the most advanced conversation intelligence platform with deep pharma expertise and proven capability development methodologies to deliver measurable field force transformation

Our offering has driven value in 5 of the top 10 pharma companies globally (& the NHS) across commercial, medical & market access

“The data is stupendously good.”

Top 10 Pharma SFE lead

“The depth of insight and level of visibility is unprecedented. There is so much we can do with this.”

Top 5 Pharma Marketing Lead

“This innovative tool offered a unique perspective on my engagements, and it provided detailed feedback that I might not have noticed or considered before.”

Top 10 Pharma Primary Care KAM

“The report gave me valuable insight on key areas of focus, as well as areas to deprioritise. It also took so much admin off my plate.”

Top 5 Pharma MSL

“My session with the NeoOptima coach was extremely helpful. They were brilliant at helping me reflect on the data and uncover what I would do differently as a result”

Top 20 Pharma Commercial Rep
  • 90% +-

    90% +-

    HCP consent for conversations to be recorded and analysed by AI

  • +25%

    +25%

    Relative increase in 'HCP Agreement to prescribe' outcome between 1st and 2nd recordings

  • +36%

    +36%

    Increase in conversations that facilitated change

  • +35%

    +35%

    Relative increase in 'deeper questioning'

Explore our latest case studies
Featured white papers
We use essential cookies to make our site work. With consent, we may also use non-essential cookies to improve user experience and analyse website traffic. By clicking ‘Accept,’ you agree to our website’s cookie use as described in our and . You can change your cookie settings at any time from either of those pages.